跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 斯婷
副教授
腫瘤惡化卓越研究中心
臨床醫學研究所
電話
(02)2826-7045
電子郵件
chensztin
ym.edu
tw
h-index
h10-index
h5-index
1016
引文
13
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
357
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
178
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2024
每年研究成果
概覽
指紋
網路
研究成果
(20)
類似的個人檔案
(6)
指紋
查看啟用 Szu-Ting Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Dengue Virus
100%
CLEC5A
91%
C-type Lectin
73%
NLRP12
53%
Human Macrophages
50%
Inflammasome Activation
46%
Interleukin-1β
45%
Macrophages
43%
Influenza Virus
43%
Lethality
43%
Dengue Infection
43%
NLRP3 Inflammasome
39%
Japanese Encephalitis Virus
36%
Innate Immunity
35%
Inflammatory Cytokines
31%
DAP12
31%
Inflammatory Response
31%
Granulocyte Colony-stimulating Factor (G-CSF)
30%
Neuroinflammation
30%
NOD-like Receptors
29%
Viral
28%
Myeloid Cells
26%
Flavivirus
26%
Lectin
26%
Interleukin-18 (IL-18)
26%
Cell Death
25%
Central Nervous System
23%
Inflammation
22%
Kaposi's Sarcoma-associated Herpesvirus
21%
Flavivirus Infection
21%
Host Protection
21%
Decoy Receptor 3 (DcR3)
21%
Virus Pathogenicity
21%
Pulmonary Inflammation
21%
Herpesvirus Reactivation
21%
Human Immunodeficiency Virus Type 1 (HIV-1)
21%
RIG-I-like Receptors
21%
Macrophage Activation
21%
Macrophage Subsets
21%
Innate Immune Checkpoint
21%
IFN Signature
21%
Long Non-coding RNA (LncRNA)
21%
ORF8 Protein
21%
Listeria Infection
21%
Antiangiogenic
21%
Inflammation Regulation
21%
AIDS/HIV
21%
Rheumatoid Arthritis Patients
21%
Synthetic Glycolipid
21%
Autophagy
21%
Immunology and Microbiology
Dengue Virus
98%
Macrophage
91%
C-Type Lectin
85%
NLRP12
56%
Myeloid
55%
Proinflammatory Cytokine
52%
Inflammasome
47%
Influenza Virus
43%
Viral Disease
42%
Immunity
41%
NOD-like Receptor
36%
Innate Immune System
35%
Japanese Encephalitis Virus Group
33%
Japanese Encephalitis Virus
33%
Lectin
31%
Interleukin-1
31%
Influenzavirus A
28%
Flavivirus
26%
Dengue Fever
26%
Homeostasis
26%
Cell Death
24%
Immune Response
22%
Human Immunodeficiency Virus
21%
Virus Virulence
21%
Osteoclast Activity
21%
Pulmonary Inflammation
21%
Human Immunodeficiency Virus 1
21%
Influenza
21%
Inflammation Response
21%
Parasitic Disease
21%
Macrophage Activation
21%
RIG-I
21%
Spike
21%
Macrophage Subset
21%
Nephritis
21%
Virus Transmission
21%
Listeriosis
21%
Lupus Erythematosus
21%
Human Herpesvirus 8
21%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Vaccine Adjuvant
21%
Inflammatory Arthritis
21%
Autophagy
21%
TLR4
21%
Gammaherpesvirus
21%
B Cell
21%
Pattern Recognition Receptor
21%
Interleukin 18
19%
Wild Type Mouse
16%
Osteoclast
14%
